Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LO SIMPESSE

ETHINYL ESTRADIOL; LEVONORGESTREL

Standard Dose
0.02MG,0.1MG;0.01MG,N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LO SIMPESSE is listed in Drugs@FDA under application 206852 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; LEVONORGESTREL Form and strength TABLET;ORAL - 0.02MG,0.1MG;0.01MG,N/A Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2025-06-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview LO SIMPESSE is listed in Drugs@FDA under application 206852 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; LEVONORGESTREL Form and strength TABLET;ORAL - 0.02MG,0.1MG;0.01MG,N/A Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2025-06-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
LO SIMPESSE (ETHINYL ESTRADIOL; LEVONORGESTREL) | Drug Monograph | MedicHelpline